Translational Control Elements in the Major Human Transforming Growth Factor-β1 mRNA

References

• Akhurst R. J., Fee F., Balmain A. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature 1988; 331: 363–365
   PubMed Web of Science ®Google Scholar
• Arrick B. A., Grendell R. L., Griffin L. A. Enhanced translational efficiency of a novel transforming growth factor β3 mRNA in human breast cancer cells. Mol. Cell Biol. 1994; 14: 619–628
   PubMed Web of Science ®Google Scholar
• Arrick B. A., Lee A. L., Grendell R. L., Derynck R. Inhibition of translation of transforming growth factor-β3 mRNA by its 5′ untranslated region. Mol. Cell Biol. 1991; 11: 4306–4313
   PubMed Web of Science ®Google Scholar
• Braun L., Mead J. E., Panzica M., Mikumo R., Bell G. I., Fausto N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA 1988; 85: 1539–1543
   PubMed Web of Science ®Google Scholar
• Brewer C. Cytomegalovirus plasmid vectors for permanent lines of polarized epithelial cells. Methods Cell Biol. 1994; 43: 233–245, (Pt. A)
   PubMedGoogle Scholar
• Chevrier D. C., Vezina C., Bastille J., Linard C., Sonenberg N., Boileau G. Higher order structures of the 5′-proximal region decrease the efficiency of translation of the porcine pro-opiomelanocortin mRNA. J. Biol. Chem. 1988; 263: 902–910
   PubMedGoogle Scholar
• Church G. M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA 1984; 81: 1991–1995
   PubMed Web of Science ®Google Scholar
• Czaja M. J., Flanders K. C., Biempica L., Klein C., Zern M. A., Weiner F. R. Expression of tumor necrosis factor-alpha and transforming growth factor-β1 in acute liver injury. Growth Factors 1989a; 1: 219–226
   PubMed Web of Science ®Google Scholar
• Czaja M. J., Weiner F. R., Flanders K. C., Giambrone M. A., Wind R., Biempica L., Zern M. A. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J. Cell Biol. 1989b; 108: 2477–2482
   PubMed Web of Science ®Google Scholar
• Danielpour D. Induction of transforming growth factor-fi autocrine activity by all-trans-retinoic acid and 1α,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. J. Cell Physiol. 1996; 166: 231–239
   Google Scholar
• Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Roberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–705
   PubMed Web of Science ®Google Scholar
• Fowlis D. J., Flanders K. C., Duffie E., Balmain A., Akhurst R. J. Discordant transforming growth factor β1 RNA and protein localization during chemical carcinogenesis of the skin. Cell Growth Differ. 1992; 3: 81–91
   PubMedGoogle Scholar
• Gorsch S. M., Memoli V. A., Stukel T. A., Gold L. I., Arrick B. A. Immunohistochemical staining for transforming growth factor, 31 associates with disease progression in human breast cancer. Cancer Res. 1992; 52: 6949–6952
   PubMed Web of Science ®Google Scholar
• Graham F., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456–467
   PubMed Web of Science ®Google Scholar
• Grens A., Scheffler I. E. The 5′-and 3′-untranslated regions of ornithine decarboxylase mRNA affect the translation efficiency. J. Biol. Chem. 1990; 265: 11810–11816
   PubMedGoogle Scholar
• Hershey J. W.B. Translational control in mammalian cells. Annu. Rev. Biochem. 1991; 60: 717–755
   PubMed Web of Science ®Google Scholar
• Huang F., Newman E., Theodorescu D., Kerbel R. S., Friedman E. Transforming growth factor β1 (TGFβ1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF-β1 antisense expression plasmid. Cell Growth Differ. 1995; 6: 1635–1642
   PubMedGoogle Scholar
• Kim S. J., Glick A., Sporn M. B., Roberts A. B. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol. Chem. 1989; 264: 402–408
   PubMed Web of Science ®Google Scholar
• Kim S. J., Park K., Koeller D., Kim K. Y., Wakefield L. M., Sporn M. B., Roberts A. B. Post-transcriptional regulation of the human transforming growth factor-β1 gene. J. Biol. Chem. 1992; 267: 13702–13707
   PubMed Web of Science ®Google Scholar
• Kondaiah P., Van Obberghen-Schilling E., Ludwig R. L., Dhar R., Sporn M. B., Roberts A. B. cDNA cloning of porcine transforming growth factor-β1 mRNAs. Evidence for alternate splicing and polyadenylation. J. Biol. Chem. 1988; 263: 18313–18317
   PubMed Web of Science ®Google Scholar
• Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA 1986; 83: 2850–2854
   PubMed Web of Science ®Google Scholar
• Kozak M. An analysis of 5′-non-coding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987; 15: 8125–8148
   PubMed Web of Science ®Google Scholar
• Kozak M. The scanning model for translation: an update. J. Cell Biol. 1989a; 108: 229–241
   PubMed Web of Science ®Google Scholar
• Kozak M. Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell Biol. 1989b; 9: 5134–5142
   PubMed Web of Science ®Google Scholar
• Kozak M. An analysis of vertebrate mRNA sequences: intimations for translational control. J. Cell Biol. 1991; 115: 887–903
   PubMed Web of Science ®Google Scholar
• Kulkarni A. B., Huh C. G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M., Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 1993; 90: 770–774
   PubMed Web of Science ®Google Scholar
• Lafyatis R., Lechleider R., Kim S. J., Jakowlew S., Roberts A. B., Sporn M. B. Structural and functional characterization of the transforming growth factor β3 promoter. A cAMP-responsive element regulates basal and induced transcription. J. Biol. Chem. 1990; 265: 19128–19136
   PubMed Web of Science ®Google Scholar
• Lehnert S. A., Akhurst R. J. Embryonic expression pattern of TGF β3 type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 1988; 104: 263–273
   PubMed Web of Science ®Google Scholar
• Manzella J. M., Blackshear P. J. Regulation of rat ornithine decarboxylase mRNA translation by its 5′-untranslated region. J. Biol. Chem. 1990; 265: 11817–11822
   PubMed Web of Science ®Google Scholar
• Markowitz S. D., Roberts A. B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine & Growth Factor Rev. 1996; 7: 93–102
   PubMedGoogle Scholar
• Millan F. A., Denhez F., Kondaiah P., Akhurst R. J. Embryonic gene expression patterns of TGF β1, β2 and β3 suggest different developmental functions in vivo. Development 1991; 111: 131–143
   PubMed Web of Science ®Google Scholar
• Muller A. J., Witte O. N. The 5′ non-coding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation. Mol. Cell Biol. 1989; 9: 5234–5238
   PubMed Web of Science ®Google Scholar
• Noma T., Glick A. B., Geiser A. G., O'Reilly M. A., Miller J., Roberts A. B., Sporn M. B. Molecular cloning and structure of the human transforming growth factor-β2 gene promoter. Growth Factors 1991; 4: 247–255
   PubMed Web of Science ®Google Scholar
• Ostrowski L. E., Gray T. E., Randell S. H., Nettesheim P. Characterization of a third transforming growth factor PI transcript in rat tracheal epithelial cells. Cell Growth Differ. 1993; 4: 985–991
   Google Scholar
• Parkin N. A., Darveau A., Nicholson R., Sonenberg N. Cis-acting translational effects of the 5′ noncoding region of c-myc mRNA. Mol. Cell Biol. 1988; 8: 2875–2883
   PubMed Web of Science ®Google Scholar
• Pelton R. W., Saxena B., Jones M., Moses H. L., Gold L. I. Immunohistochemical localization of TGF β1, TGF β2, and TGF β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 1991; 115: 1091–1105
   PubMed Web of Science ®Google Scholar
• Phillips A. O., Topley N., Steadman R., Morrisey K., Williams J. D. Induction of TGF-β1 synthesis in D-glucose primed human proximal tubular cells by IL-1β and TNF-α. Kidney Int. 1996; 50: 1546–1554
   PubMed Web of Science ®Google Scholar
• Proetzel G., Pawlowski S. A., Wiles M. V., Yin M., Boivin G. P., Howies P. N., Ding J., Ferguson M. W.J, Doetschman T. Transforming growth factor-β3 is required for secondary palate fusion. Nat. Genet. 1995; 11: 409–414
   PubMed Web of Science ®Google Scholar
• Qian S. W., Kondaiah P., Casscells W., Roberts A. B., Sporn M. B. A second messenger RNA species of transforming growth factor β in infarcted rat heart. Cell Regul. 1991; 2: 241–249
   PubMedGoogle Scholar
• Rao D. C., Pech M., Robbins K. C., Aaronson S. A. The 5′ untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor. Mol. Cell Biol. 1988; 8: 284–292
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Sporn M. B. Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, M. B. Sporn, A. B. Roberts. Springer-Verlag, Berlin 1990; Vol. 95/I: 419–472
   Google Scholar
• Romeo D., Allison R. S.H., Kondaiah P., Wakefield L. M. Recharacterization of the start sites for the major human transforming growth factor-β1 mRNA. Gene 1997; 189: 289–295
   Google Scholar
• Romeo D. S., Park K., Roberts A. B., Sporn M. B., Kim S. J. An element of the transforming growth factor-β1 5′-untranslated region represses translation and specifically binds a cytosolic factor. Mol. Endocrinol. 1993; 7: 759–766
   PubMedGoogle Scholar
• Sanford L. P., Ormsby I., Gittenberger-de Groot A. C., Sariola H., Friedman R., Boivin G. P., Cardell E. L., Doetschman T. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 1997; 124: 2659–2670
   PubMed Web of Science ®Google Scholar
• Scotto L., Assoian R. K. A GC-rich domain with bifunctional effects on mRNA and protein levels: implications for control of transforming growth factor β1 expression. Mol. Cell Biol. 1993; 13: 3588–3597
   PubMedGoogle Scholar
• Scotto L., Vaduva P. I., Wager R. E., Assoian R. K. Type β transforming growth factor gene expression. A corrected mRNA structure reveals a downstream phorbol ester responsive element in human cells. J. Biol. Chem. 1990; 265: 2203–2208
   PubMedGoogle Scholar
• Steiner M. S., Barrack E. R. Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol. 1992; 6: 15–25
   PubMed Web of Science ®Google Scholar
• Thompson N. L., Bazoberry F., Speir E. H., Casscells W., Ferrans V. J., Flanders K. C, Kondaiah P., Geiser A. G., Sporn M. B. Transforming growth factor β-1 in acute myocardial infarction in rats. Growth Factors 1988; 1: 91–99
   PubMedGoogle Scholar
• Thompson N. L., Flanders K. C, Smith J. M., Ellingsworth L. R., Roberts A. B., Sporn M. B. Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol. 1989; 108: 661–669
   PubMed Web of Science ®Google Scholar
• Wu S. P., Theodorescu D., Kerbel R. S., Willson J. K., Mulder K. M., Humphrey L. E., Brattain M. G. TGF-β1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol. 1992; 116: 187–196
   PubMed Web of Science ®Google Scholar